Overview Fundamentals API Earnings EOD API Sample Code Pricing

2Seventy Bio Inc (TSVT NASDAQ) stock market data APIs

$4.13 0.21(5.4%) as of November 14, 2024
Price chart is built with Anychart

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

2Seventy Bio Inc Financial Data Overview

3.92
4.13
-
4.3195
3.9
1.535-6.4
220 M
51 498 K
44 120 K
-0.1901
1.786
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TSVT',
Type: 'Common Stock',
Name: '2Seventy Bio Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YV1J622',
ISIN: NULL,
CUSIP: NULL,
CIK: '1860782',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-11-03',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

2Seventy Bio Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 44 120 K
  • EBITDA -176 560 000
  • Earnings Per Share -3.06
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get 2Seventy Bio Inc Earnings via APIs

  • Latest Release 2024-11-12
  • EPS/Forecast -0.24

Get 2Seventy Bio Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com